USF Health Byrd Alzheimer’s Center and Research Institute

Current Clinical Trials

There is currently no way to stop the progression of Alzheimer’s disease. Clinical trials are necessary in order to find new treatments. Our center is involved in a number of research studies for people with mild cognitive impairment (MCI) as well as mild to moderate Alzheimer’s disease. We also have prevention studies for older individuals who have no memory loss. We have some trials which are only observational, evaluating changes in memory over time in participants, as well as trials investigating new treatments. These treatments may involve pills, while others use injections or infusions in a vein. Some of our studies involve brain imaging techniques such as PET scans to detect proteins in the brain associated with memory loss and Alzheimer’s disease.  

The Byrd Institute is very pleased to announce a new study
we are currently conducting that is aimed to delay or prevent Alzheimer's. 
Please read this article for more information .

 

Currently Enrolling Clinical Trials

> For Patients WITH Memory Loss
  • A 4-year observational study involving cognitive testing and neuroimaging, which may help to learn more about Alzheimer’s disease. This study is for patients 55-90 years old with mild cognitive impairment or mild Alzheimer’s disease.

  • An 18-month trial investigating an infusion-based treatment which may reduce amyloid plaque in the brain. This study is for patients with mild cognitive impairment or mild Alzheimer's disease.
> For Individuals WITHOUT Memory Loss

  • A 5-year study involving cognitive testing and neuroimaging, which is intended to help recruit for future Alzheimer's prevention studies. This study is for individuals 50-85 years old who currently have no memory  problems.

 

Upcoming Clinical Trials

> For Patients WITH Memory Loss
  • A 76-week trial investigating an infusion-based treatment which may reduce amyloid plaque and tau tangles in the brain. This study is for patients 60-85 years old with mild Alzheimer's disease.
> For Individuals WITHOUT Memory Loss
  • A 4-year "prevention" study investigating an infusion-based treatment which may reduce amyloid plaque in the brain. This study is for individuals 55-80 years old who currently have no memory problems.

 


We always have new trials just around the corner. Please check back with us for updates!

For more information about our programs, contact
Kelly Rodrigo at (813) 974-4904 or blackmer@usf.edu


Links for Finding Clinical Trials